Thursday, November 19
    Home>> Business>>WuXi Biologics CEO expects approval for Covid-19 antibody treatment ‘late this year or early next year’
    Business

    WuXi Biologics CEO expects approval for Covid-19 antibody treatment ‘late this year or early next year’

    AdminNovember 19, 2020 0 Views0
    Related tags : Eli Lilly and CoFDAWuXi Biologics (Cayman) Inc

    Related Articles

    Business

    Sensex Slumps Over 400 Points, Nifty Below 11,200; Banking, Metal Shares Bleed

    Business

    Hong Kong-Singapore travel bubble could begin in November, Hong Kong finance secretary says

    Business

    With test delays across country, Kroger and CVS Health say they can help businesses, college campuses

    Business

    Recovery Hopes Dashed For India’s Recession-Hit Economy: Poll

    Business

    There’s a path for Biden to approve Keystone XL, but some Canadians aren’t going to like it

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    %d bloggers like this: